These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2595662)

  • 41. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
    Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC
    Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue factor activity of cultured human lymphocytes.
    Goutner A; Beguin S; Josso F
    Biomedicine; 1975 Jul; 22(4):298-302. PubMed ID: 132201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue factor-like activity of the human monocytic tumor cell line U937.
    Hudig D; Bajaj SP
    Thromb Res; 1982 Aug; 27(3):321-32. PubMed ID: 6753233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary characterization of the procoagulant material in human ascites.
    Addonizio VP; Fisher CA; Strauss JF; Ewan VA; Rickles FR; Rosato EF; Harken AH; Inouye WY
    Surgery; 1987 Jun; 101(6):753-62. PubMed ID: 3589968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the cell-surface procoagulant activity of T-lymphoblastoid cell lines.
    Pickering W; Gray E; Goodall AH; Ran S; Thorpe PE; Barrowcliffe TW
    J Thromb Haemost; 2004 Mar; 2(3):459-67. PubMed ID: 15009464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors of the extrinsic pathway of blood coagulation in tumour associated macrophages.
    Adány R; Kappelmayer J; Berényi E; Szegedi A; Fábián E; Muszbek L
    Thromb Haemost; 1989 Nov; 62(3):850-5. PubMed ID: 2595659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay.
    Debaugnies F; Azerad MA; Noubouossié D; Rozen L; Hemker HC; Corazza F; Efira A; Demulder A
    Thromb Res; 2010 Dec; 126(6):531-5. PubMed ID: 20870277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phospholipid requirements of tissue thromboplastin in blood coagulation.
    Liu DT; McCoy LE
    Thromb Res; 1975 Jul; 7(1):213-221. PubMed ID: 1154339
    [No Abstract]   [Full Text] [Related]  

  • 49. Normal hemostatic mechanisms: a review.
    Pool JG
    Am J Med Technol; 1977 Aug; 43(8):776-80. PubMed ID: 888856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of apoptosis and lipid peroxidation on T-lymphoblastoid phospholipid-dependent procoagulant activity.
    Pickering W; Gray E; Goodall AH; Barrowcliffe TW
    J Thromb Haemost; 2008 Jul; 6(7):1122-30. PubMed ID: 18601681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Dynamics of peripheral nerve procoagulant and fibrinolytic activity upon electrical stimulation].
    Kuznik BI; Malezhik LP; Molchanova NL; Rusiaev VF
    Fiziol Zh SSSR Im I M Sechenova; 1979 Mar; 65(3):414-20. PubMed ID: 456659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence that cells from experimental tumours can activate coagulation factor X.
    Curatolo L; Colucci M; Cambini AL; Poggi A; Morasca L; Donati MB; Semeraro N
    Br J Cancer; 1979 Aug; 40(2):228-33. PubMed ID: 573131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of procoagulant activity in human epidermal cells.
    Schöne A; Zimmermann E; Knop J
    Arch Dermatol Res; 1989; 281(5):316-20. PubMed ID: 2802662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinctive features of procoagulant response of monocytes from diabetic patients.
    Jude B; Watel A; Fontaine O; Fontaine P; Cosson A
    Haemostasis; 1989; 19(2):65-73. PubMed ID: 2731777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of tissue thromboplastin activity.
    Wijngaards G; Hemker HC
    Haemostasis; 1977; 6(2):89-97. PubMed ID: 558936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Procoagulant activity in renal transplant recipients.
    Halloran PF; Aprile MA; Haddad GJ; Robinette MA
    Transplantation; 1985 Apr; 39(4):374-7. PubMed ID: 3920795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. More on: on the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells.
    Solly F; Pernod G
    J Thromb Haemost; 2006 Oct; 4(10):2289-90. PubMed ID: 16856977
    [No Abstract]   [Full Text] [Related]  

  • 58. A coupled amidolytic assay for thromboplastin (tissue factor) using a fluogenic substrate: its application to monkey leukocyte tissue factor.
    Nakamura S
    J Biochem; 1985 Feb; 97(2):705-7. PubMed ID: 4008476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of tumor cell procoagulant activity by Sonoclot analysis in whole blood.
    Amirkhosravi A; Biggerstaff JP; Warnes G; Francis DA; Francis JL
    Thromb Res; 1996 Dec; 84(5):323-32. PubMed ID: 8948059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioassay of procoagulant albumin in human plasma.
    Grosset A; Liu L; Parker CJ; Rodgers GM
    Thromb Res; 1994 Sep; 75(5):551-8. PubMed ID: 7992255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.